The United States FDA approves three doses of COVID-19 vaccine for immunocompromised persons
It is announced that The United States Food and Drug Administration (FDA) approved the third dose of COVID-19 vaccine for immunocompromised persons on August 12. In a statement, FDA Interim Commissioner Janet Woodcock said “The next COVID-19 epidemic in the United States is on the rise. The FDA considers immunocompromised persons to be especially at … Read more